Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders

Holmes GP, Kaplan JE, Gantz NM et al. Chronic fatigue syndrome: a working definition. Ann Intern Med1988;108:387–9.

Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff AL. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med1994;121:953–9.

Nishikai M, Akiya K, Tojo T, Onoda N, Tani M, Shimizu K. ‘Seronegative’ Sjögren's syndrome manifested as a subset of chronic fatigue syndrome. Br J Rheumatol1996;35:471–4.

Nishikai M, Kosaka S. Antinuclear and anticytoplasmic autoantibodies in chronic fatigue syndrome. In: Kitani T, ed, Annual Reports of Ministry of Health and Welfare: Research Committee on Epidemiology and Pathogenesis of Chronic Fatigue Syndrome. Tokyo: Ministry of Health and Welfare, 1995:34–5.

Bates DW, Buchwald D, Lee J et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Ann Intern Med1995;155:97–103.

Nishikai M, Kosaka S. Incidence of antinuclear antibodies in Japanese patients with chronic fatigue syndrome. Arthritis Rheum1997;40:2095–7.

Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest1996;98:1888–96.

Von Mikecz A, Konstantinov K, Buchwald DS, Gerace L, Tan EM. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum1997;40:295–305.

Itoh Y, Fukunaga Y, Igarashi T et al. Autoimmunity in chronic fatigue syndrome. Jpn J Rheumatol1998; 8:429–37.

Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum1990;33:160–72.

Beck AT, Beck RW. Screening depressed patients in family practice. A rapid technique. Postgrad Med1972;52:81–5.

Spitzer RL, Williams JBW, Gibbon M, First MB. Structured clinical interview for DSM‐III‐R (SCID) user's guide. Washington, DC: American Psychiatric Press, 1990.

Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982;25:1271–7.

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;31:315–24.

Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo‐1 antibody system. Arthritis Rheum1980;23:881–8.

Laemmli UK. Cleavage of structural proteins during assembly at the head of the bacteriophage T4. Nature1970;227:680–2.

Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL. The ``chronic, active Epstein‐Barr virus infection” syndrome and primary fibromyalgia. Arthritis Rheum1987;30:1132–6.

Nishikai M. Clinical study on similarity between chronic fatigue syndrome and fibromyalgia. J Jpn Med Assoc1992;107:1695–1700.

Nishikai M. Primary fibromyalgia and chronic fatigue syndrome: Are these diseases identical? J Musculoskel Pain1995;3(Suppl. 1):40.

Diagnostic Classification Steering Committee, Thorpy MJ, Chairman. International classification of sleep disorders: diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1990.

Song C, Bonaccorso S, Heide C et al. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Dis1998;49:211–9.

Darko DF, Mitler MM, Henriksen SJ. Lentiviral infection, immune response peptides and sleep. Adv Neuroimmunol1995;5:57–77.

Moldofsky H. Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome. Adv Neuroimmunol1995;5:39–56.

Schenk CH, Garcia‐Rill W, Segall M, Noreen H, Mahowald MW. HLA class II genes associated with REM sleep behavior disorder. Ann Neurol1996; 39:261–3.

Schenk CH, Ullevig CM, Mahowald NW, Dalmau J, Posner JB. A controlled study of serum anti‐locus ceruleus antibodies in REM sleep behavior disorder. Sleep1997; 20:349–51.

Nishikai M. Fibromyalgia in Japanese. J Rheumatol1992; 19:110–4.

Brauchitsch H. Antinuclear factor in psychiatric disorders. Am J Psychiat1972;128:1552–4.

Johnstone EC, Whaley K. Antinuclear antibodies in psychiatric illness: Their relationship to diagnosis and drug treatment. Br Med J1975;2:724–5.